Alterations in TGFβ signaling has been reported in teratocarcinoma development in vitro and in vivo[43] and the mouse teratoma-derived cell line showed increased tumorigenic properties with decreased TGFβ response [44]. The gene discussed is TGFB1; the disease is teratocarcinoma.